jrnls.org logo
Submit

BROWSE ALL JOURNALS

Type 2 letters to search all 19 journals

SEE ALL 19 JOURNALS
Pharmacognosy MagazineNOW IN
Article

Naringin, a Natural Flavonone Glycoside attenuates N-Nitrosodiethylamine- induced Hepatocellular Carcinoma in Sprague-Dawley rats

1, 1, 1, 1, 1, 2, 3, 4★★ Corresponding author

  1. 1Department of Pharmaceutical Sciences and Technology, Division of Pharmacology, Birla Institute of Technology, Ranchi, Jharkhand, India.
  2. 2Department of Biotechnology, Birla Institute of Technology, Ranchi, Jharkhand, India.
  3. 3Department of Health, Family Welfare and Medical Education, Government Pharmacy Institute, Government of Jharkhand, Ranchi, Jharkhand, India.
  4. 4Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Government of India, Gaya, Bihar, India.

CORRESPONDENCE

Shakti Prasad Pattanayak

Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Government of India, Gaya, Bihar, India.

sppattanayak@cusb.ac.in

Received: 25-02-2021; Revised: 30-03-2021; Accepted: 30-04-2021.

Volume 17, Issue 6S · pp. S196–S204 · 2021 · DOI: 10.4103/pm.pm_94_21

View on PM original site ↗

ABSTRACT

Objectives: The present research work focuses on evaluation of chemotherapeutic efficiency, NAR against HCC in Sprague– Dawley rats.Materials and Methods: In vitro studies were primarily carried out to estimate the cell viability of NAR in HepG2 cells followed by further justifications through in vivo studies in N‑nitrosodiethylamine developed HCC. The efficacy of NAR at doses 30mg/kg/day and 60mg/kg/ day was assessed through estimation of liver marker enzymes, antioxidant levels, glycoproteins, and level of MMP‑2 and 9 to confirm the hypothesis.Results: While in vitro results revealed pronounced potency of NAR in inhibiting HepG2 cell viability, NAR concurrently stabilized the serum levels of liver marker enzymes, antioxidant levels, and serum glycoproteins. It also significantly reduced the levels of MMPs in treatment groups which was confirmed by zymography.Conclusion: With the support of these results, it can be concluded that NAR attenuates HCC by controlling the alterations in morphological, biochemical, and histopathological parameters that make it a suitable candidate as a potential chemotherapeutic agent against HCC.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Acharya, R., Mishra, N., Kumar, A., Bose, P., Pattnaik, A., Mukhopadhyay, K., Sunita, P., & Pattanayak, S. P. (2021). Naringin, a Natural Flavonone Glycoside attenuates N-Nitrosodiethylamine- induced Hepatocellular Carcinoma in Sprague-Dawley rats. Pharmacognosy Magazine, 17(6S), S196–S204. https://doi.org/10.4103/pm.pm_94_21